Found: 1
Select item for more details and to access through your institution.
The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 7, p. 209, doi. 10.1177/2040620717710171
- By:
- Publication type:
- Article